At what enterprise value was KARO HEALTHCARE acquired in 2025?

During the acquisition of KARO HEALTHCARE by KKR in 2025, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Retail & Consumer industry currently tracks an average EBITDA multiple of 11.0x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of KARO HEALTHCARE when it was acquired by KKR?

The estimated EV/EBITDA multiple for KARO HEALTHCARE is in the range of 15x - 25x. For comparison, the Retail & Consumer sector currently shows an average EBITDA multiple of 11.0x. Join our community for free to access full valuation data and industry trends.

When was KARO HEALTHCARE acquired by KKR?

KARO HEALTHCARE was acquired by KKR in 2025.

What was the revenue of KARO HEALTHCARE at the time of the deal?

The revenue of KARO HEALTHCARE at the time of the deal is estimated to be in the range of 450M - 900M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of KARO HEALTHCARE during the acquisition?

KARO HEALTHCARE's EBITDA is estimated to be in the range of 100M - 200M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the KARO HEALTHCARE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the KARO HEALTHCARE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.karohealthcare.com/karo-healthcare-announces-kkr-as-new-owner-following-successful-strategic-transformation-into-pan-european-consumer-healthcare-player/

← DATABASE

Home Database Retail & ConsumerKARO HEALTHCARE

08/2025

KARO HEALTHCARE acquired by KKR

SWEDEN Consumer Products / Personal & Household / Hygiene & Beauty Brands EV 1b - 4b EUR

Context

KKR has finalized the 100% acquisition of Karo Healthcare from the EQT VIII fund in a transaction initially announced in April 2025. The strategic rationale for KKR is to capitalize on a pan-European platform already structured for significant scale. Following a period where revenues quadrupled under EQT, Karo is entering an international acceleration phase. KKR plans to leverage its global footprint to deepen Karo’s reach across new distribution channels and geographies, while continuing to consolidate the fragmented sector through targeted bolt-on acquisitions. The transaction was advised by Citigroup and J.P. Morgan for KKR, and Morgan Stanley and Jefferies for EQT.

KARO HEALTHCARE, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Retail & Consumer sector (11.0x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Retail & Consumer market trends

Target

Karo Healthcare is a leading European platform specialized in over-the-counter (OTC) consumer healthcare products. Under EQT's ownership, the company underwent a radical transformation, evolving from a Nordic specialty pharma player into a pan-European champion. Its portfolio focuses on trusted brands in resilient categories: Skin Health, Foot Health, Intimate Health, Digestive Health, and Vitamins, Minerals & Supplements (VMS). Present in over 90 countries, Karo relies on a highly digitized commercial platform and a mixed growth model combining organic performance with an aggressive "Buy-and-Build" strategy, evidenced by eight acquisitions completed since 2019.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Retail & Consumer

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
10/2025	FRENCH FOOD CAPITAL / BPIFRANCE	SABRE PARIS	FRANCE	Consumer Products	The acquisition of a majority stake in Sabre Paris by FrenchFood Capital marks a significant milestone in the company's history, as it seeks to consolidate its growth trajectory and affirm its position in strategic international markets
09/2025	PLATINUM EQUITY	XD CONNECTS	NETHERLANDS	Consumer Products	Platinum Equity acquired XD Connects from Rivean Capital (formerly Gilde Buy Out Partners). The deal was structured as a merger with Solo Group to create a market leader with a ~10% market share in Europe
06/2025	KONTOOR BRANDS	HELLY HANSEN	NORWAY	Consumer Products	Kontoor Brands has completed the acquisition of 100% of Helly Hansen, marking a transformative step in the group’s portfolio expansion strategy. This acquisition significantly increases Kontoor’s geographic diversification, particularly in Europe and the technical outdoor segment, while providing a powerful "third pillar" alongside Wrangler and Lee
06/2025	PARTNERS GROUP	MPM	UNITED KINGDOM	Consumer Products	Partners Group has agreed to acquire a majority stake in MPM Products, the owner of premium cat food brands Applaws, Reveal, and Encore, from 3i Group. This acquisition marks the next phase of global expansion for the Manchester-based company
06/2025	PLATINUM EQUITY	SOLO GROUP	FRANCE	Consumer Products	Platinum Equity acquired 100% of Solo Group from the founder and management. Shortly after, Platinum acquired Dutch competitor XD Connects and merged it with Solo under a new holding entity (Sun II Ltd.)...
05/2025	AUTHENTIC BRANDS GROUP	DOCKERS	UNITED STATES	Consumer Products	Levi Strauss & Co. agreed to sell Dockers to Authentic Brands Group. The transaction transfers the Dockers brand out of Levi Strauss’ portfolio and into Authentic’s intellectual-property-led model, with the operational rollout expected to be handled through licensing and partner relationships rather than through a traditional owned-retail structure
04/2025	BRICONORD	SCELL-IT	FRANCE	Consumer Products	The Briconord Group acquires Scell-it, a strategic move that strengthens its position in the professional fastening market. This acquisition is the 6th build-up for Briconord in recent years. By integrating Scell-it, Briconord expands its product portfolio to include high-tech fastening systems and tools, creating strong cross-selling opportunities across its European distribution networks
03/2025	USHOPAL GROUP	PAYOT	FRANCE	Consumer Products	Ushopal acquired 100% of Payot from LBO France (which held 80% since 2014) and the management team. The transaction concludes a long holding period marked by two previously aborted sales processes (2019 and 2021) due to the pandemic and geopolitical risks in Russia
02/2025	BC PARTNERS	PETLAB	UNITED KINGDOM	Consumer Products	BC Partners acquired a majority stake in PetLab Co. from its co-founders, who retained a significant minority investment in the business. The transaction leverages BC Partners’ specialized knowledge in the pet ecosystem—specifically its experience in scaling Chewy Health—to accelerate the target's international expansion and product innovation
01/2025	VERDOSO	THE KOOPLES	FRANCE	Consumer Products	The transaction involves the 100% sale of The Kooples by MF Brands Group to Verdoso, a French industrial group specializing in the turnaround and transformation of distressed assets. This strategic exit allows the seller to offload a non-core, loss-making fashion label and refocus on its global premium brands like Lacoste

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 450M - 900M EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of KARO HEALTHCARE by KKR are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: kkr